# Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia

> **NCT00607256** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 500 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** [S,S]-reboxetine

## Key facts

- **NCT ID:** NCT00607256
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10-20
- **Primary completion:** 2009-05-18
- **Final completion:** 2009-05-18
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607256, "Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00607256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*